Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV‐infected patients

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Clinical and Experimental Immunology

• Publication date

  1991-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.1991.tb08146.xPMID 2025948PMCID PMC1535403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus.

  1989cited by this paper
• Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

  1988cited by this paper
• Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

  1987cited by this paper
• Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults

  1987cited by this paper
• Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.

  1987cited by this paper
• Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation.

  1987cited by this paper
• [Antibiotic resistance and serotypes of Streptococcus pneumoniae in Zurich (1984-1985)].

  1987cited by this paper
• Natural and vaccine-related immunity to Streptococcus pneumoniae.

  1986cited by this paper
• Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4.

  1985cited by this paper
• Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.

  1984cited by this paper
• Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis

  1984cited by this paper
• Long-Term Persistence of Antibody following Immunization with Pneumococcal Polysaccharide Vaccine 1

  1983cited by this paper
• Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

  1983cited by this paper
• [Measurement of human tetanus antitoxin using as enzyme-linked immunosorbent assay].

  1977cited by this paper
• The uses and results of active tetanus immunization.

  1955cited by this paper

• HIV-producing resting T cells monopolize virus production, associated PANoptosis, and persistence in lymphoid tissue

  2026cites this paper
• Immunoglobulin Replacement Therapy

  2021cites this paper
• The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population

  2018cites this paper
• 70 – Vaccination of Human Immunodeficiency Virus–Infected Persons

  2018cites this paper
• 47 – Pneumococcal Polysaccharide Vaccines

  2018cites this paper
• Fatal tetanus infection originating from fungating advanced breast cancer: Case report and review of the literature

  2018cites this paper
• Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum–Specific Atypical Memory B Cells

  2017cites this paper
• Global Considerations in Human Immunodeficiency Virus-Associated Respiratory Disease

  2016cites this paper
• HIV-associated memory B cell perturbations.

  2015cites this paper
• Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013)

  2015cites this paper
• Early goal directed therapy for adult meningitis in Malawi

  2014cites this paper
• Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?

  2013cites this paper
• humoral immunity in HIV-1 infection Mechanisms of hypergammaglobulinemia and impaired antigen-specific

  2013cites this paper
• Recurrent Tetanus in Diagnosed Breast Cancer Patients of the Philippine General Hospital

  2013cites this paper
• CD4 T Cell Help Is Limiting and Selective during the Primary B Cell Response to Influenza Virus Infection

  2013cites this paper
• B-Lymphocyte Dysfunction in Chronic HIV-1 Infection Does Not Prevent Cross-Clade Neutralization Breadth

  2012cites this paper
• Parâmetros imunovirológicos em pacientes infectados pelo HIV, tratados ou não com antirretrovirais

  2012cites this paper
• Accueil > Revues > Biologie et recherche > Texte intégral de l'article Me connecter Envoyer Recherche avancée Panier English version Nouveautés Catalogue/Recherche Collections

  2012cites this paper
• Psychosocial factors, physical activity status and antibody response to vaccination in healthy and HIV positive populations

  2012cites this paper
• Year : 2010 B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-α response to TLR 9 triggering

  2011cites this paper
• SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination.

  2011cites this paper
• Immune correlates of HIV control.

  2011cites this paper
• Les patients insuffisants rénaux chroniques ( IRC ) et notamment les patients hémodialysés présentent

  2010cites this paper
• Vaccination et insuffisance rénale chronique Vaccination and chronic kidney disease

  2010cites this paper
• A 5‐year longitudinal follow‐up study of serological responses to 23‐valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy *

  2010cites this paper
• B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-α response to TLR9 triggering.

  2010cites this paper
• Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.

  2010cites this paper
• Studies of the pathogenesis of Jembrana disease virus infection in Bos javanicus

  2010cites this paper
• Dysregulated Humoral Immunity to Nontyphoidal Salmonella in HIV-Infected African Adults

  2010cites this paper
• Immunological dysfunction in HIV‐1‐infected individuals caused by impairment of adenosine deaminase‐induced costimulation of T‐cell activation

  2009cites this paper
• Adenosine deaminase enhances T‐cell response elicited by dendritic cells loaded with inactivated HIV

  2009cites this paper
• HIV-Infected Individuals and Effector Responses of B Cells in CpG Oligonucleotides Enhance Proliferative

  2008cites this paper
• Vaccination of human immunodeficiency virus-infected persons

  2008cites this paper
• HIV-1 infection and loss of serological memory : The role of altered expression of B-cell chemokine receptors, timing of HAART and impaired antibody affinity maturation

  2008cites this paper
• Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.

  2008cites this paper
• Impfungen bei immunkompromittierten erwachsenen Patienten

  2008cites this paper
• British HIV Association guidelines for immunization of HIV‐infected adults 2008

  2008cites this paper
• Pneumococcal polysaccharide vaccines

  2008cites this paper
• CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals1

  2008cites this paper
• Chemokines and chemokine receptors during viral infections in man

  2007cites this paper
• Vaccination and chronic kidney disease.

  2007cites this paper
• Immunizations in HIV-infected adults.

  2007cites this paper
• Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.

  2006cites this paper
• Mechanisms underlying impaired humoral immunity in primary and chronic HIV-1 infection

  2006cites this paper
• Response to hepatitis A vaccine in HIV‐positive patients 1

  2006cites this paper
• Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now?

  2005cites this paper
• Vaccination of adults against travel-related infectious diseases, and new developments in vaccines

  2005cites this paper
• Studies on medical and immunological intervention in HIV-1 infection

  2004cites this paper
• New trends in the management of tetanus

  2004cites this paper
• B lymphocyte dysfunctions in HIV infection.

  2004cites this paper
• Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

  2004cites this paper
• Global strategies to prevent bacterial pneumonia in adults with HIV disease.

  2004cites this paper
• Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.

  2004cites this paper
• Medical and Immunological Interventions in HIV - 1 Infection

  2004cites this paper
• Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma

  2004cites this paper
• Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

  2003cites this paper
• Special issues in the management of patients with ESRD and HIV infection.

  2003cites this paper
• This information is current as on B Cell Costimulatory Function Deleterious Effect of HIV-1 Plasma Viremia

  2003cites this paper
• Chapter 38 – Immunizations, Vaccine-Preventable Diseases, and HIV Infection

  2003cites this paper
• Ehrlichia chaffeensis Infections among HIV-infected Patients in Human Monocytic Ehrlichiosis–Endemic Area

  2003cites this paper
• CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study.

  2003cites this paper
• Immunization of immunocompromised persons.

  2003cites this paper
• Low frequency of plasma nerve‐growth factor detection is associated with death of memory B lymphocytes in HIV‐1 infection

  2003cites this paper
• Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function

  2003cites this paper
• Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.

  2003cites this paper
• Better preserved immune responses after immunization with rgp 160 in HIV‐1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow‐up

  2003cites this paper
• Évaluation du test sanguin « Tetanos Quick Stick » (TQS) en situation d'urgence

  2002cites this paper
• Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals.

  2001cites this paper
• Loss of memory (CD27) B lymphocytes in HIV-1 infection

  2001cites this paper
• Immunization of health care workers.

  2000cites this paper
• Travel and the immunocompromised host.

  2000cites this paper
• Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

  2000cites this paper
• Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

  2000cites this paper
• [Advice to HIV infected persons travelling to tropical or subtropical destinations].

  2000cites this paper
• Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.

  2000cites this paper
• Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

  1999cites this paper
• Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).

  1999cites this paper
• Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.

  1999cites this paper
• Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients

  1998cites this paper
• [Vaccinations and systemic diseases. Vaccinations and immunosuppression].

  1998cites this paper
• Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage.

  1998cites this paper
• Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection.

  1998cites this paper
• Association of Phenotypic Changes in B Cell Lymphocytes and Plasma Viral Load in Human Immunodeficiency Virus-Infected Patients

  1998cites this paper
• Streptococcus pneumoniae bacteremia in children infected with HIV: Presentation, course, and outcome

  1998cites this paper
• Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.

  1998cites this paper
• Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host

  1998cites this paper
• Pneumococcal Vaccination of HIV-Infected Individuals: Safety and Efficacy

  1997cites this paper
• Invasive Pneumococcal Disease in the Immunocompromised Host

  1997cites this paper
• Immunization of health-care workers; recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC)

  1997cites this paper
• Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men.

  1997cites this paper
• Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection.

  1997cites this paper
• Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC).

  1997cites this paper
• [Vaccinations in immunosuppressed patients].

  1997cites this paper
• Unforgettable tetanus.

  1997cites this paper
• Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

  1996cites this paper
• Preserved neutrophil response to Candida albicans stimulation in AIDS patients with Candida esophagitis

  1996cites this paper
• Active Immunization in HIV‐infected Patients

  1996cites this paper
• Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.

  1995cites this paper
• Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.

  1995cites this paper
• Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection.

  1995cites this paper